BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang J. Clinical utility of entecavir for chronic hepatitis B in Chinese patients. Drug Des Devel Ther. 2013;8:13-24. [PMID: 24376343 DOI: 10.2147/dddt.s41423] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Li L, Liu Y, Luo T, Zhou J, Hou Y, Shen X, Wang J. Comprehensive treatment of acute-on-chronic liver failure in a patient with hepatitis B: a case report. Front Med 2014;8:250-3. [PMID: 24810647 DOI: 10.1007/s11684-014-0333-3] [Reference Citation Analysis]
2 Chi X, Pan J, Cai J, Luo G, Li S, Yuan D, Rui J, Chen W, Hei Z. Pharmacokinetic Analysis of Propofol Target-Controlled Infusion Models in Chinese Patients with Hepatic Insufficiency. Med Sci Monit 2018;24:6925-33. [PMID: 30269150 DOI: 10.12659/MSM.910103] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
3 Wang G, Liu Y, Qiu P, Zhou SF, Xu L, Wen P, Wen J, Xiao X. Cost-effectiveness analysis of lamivudine, telbivudine, and entecavir in treatment of chronic hepatitis B with adefovir dipivoxil resistance. Drug Des Devel Ther. 2015;9:2839-2846. [PMID: 26082614 DOI: 10.2147/dddt.s73150] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
4 He FL, Wang L, Yue ZD, Zhao HW, Liu FQ. Parallel transjugular intrahepatic portosystemic shunt for controlling portal hypertension complications in cirrhotic patients. World J Gastroenterol 2014; 20(33): 11835-11839 [PMID: 25206289 DOI: 10.3748/wjg.v20.i33.11835] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
5 Xu K, Liu LM, Farazi PA, Wang H, Rochling FA, Watanabe-Galloway S, Zhang JJ. Adherence and perceived barriers to oral antiviral therapy for chronic hepatitis B. Glob Health Action 2018;11:1433987. [PMID: 29447614 DOI: 10.1080/16549716.2018.1433987] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
6 Xu Y, Zhang YG, Wang X, Qi WQ, Qin SY, Liu ZH, Jiao J, Wang JB. Long-term antiviral efficacy of entecavir and liver histology improvement in Chinese patients with hepatitis B virus-related cirrhosis. World J Gastroenterol 2015; 21(25): 7869-7876 [PMID: 26167087 DOI: 10.3748/wjg.v21.i25.7869] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]